V Square Quantitative Management LLC boosted its holdings in Credicorp Ltd. (NYSE:BAP – Free Report) by 28.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,880 shares of the bank’s stock after buying an additional 630 shares during the quarter. V Square Quantitative Management LLC’s holdings in Credicorp were worth $534,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the business. MassMutual Private Wealth & Trust FSB grew its position in Credicorp by 37.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 226 shares of the bank’s stock worth $41,000 after buying an additional 62 shares during the last quarter. Wasatch Advisors LP grew its position in Credicorp by 0.7% during the 3rd quarter. Wasatch Advisors LP now owns 8,886 shares of the bank’s stock worth $1,608,000 after purchasing an additional 65 shares in the last quarter. Cerity Partners LLC grew its position in Credicorp by 3.8% during the 3rd quarter. Cerity Partners LLC now owns 3,068 shares of the bank’s stock worth $555,000 after purchasing an additional 111 shares in the last quarter. Yousif Capital Management LLC grew its position in Credicorp by 4.0% during the 4th quarter. Yousif Capital Management LLC now owns 3,489 shares of the bank’s stock worth $640,000 after purchasing an additional 135 shares in the last quarter. Finally, Crossmark Global Holdings Inc. grew its position in Credicorp by 4.6% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 3,189 shares of the bank’s stock worth $577,000 after purchasing an additional 140 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.
Credicorp Trading Up 1.1 %
Shares of NYSE:BAP opened at $185.81 on Friday. The firm has a fifty day moving average of $184.88 and a two-hundred day moving average of $181.72. The firm has a market capitalization of $14.78 billion, a P/E ratio of 10.66, a price-to-earnings-growth ratio of 0.51 and a beta of 1.12. Credicorp Ltd. has a 12-month low of $153.27 and a 12-month high of $200.00. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.66.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Credicorp from $200.00 to $219.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 12th. Bank of America cut shares of Credicorp from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $209.00 to $208.00 in a research report on Monday, December 16th.
View Our Latest Stock Report on BAP
Credicorp Profile
Credicorp Ltd. provides various financial, insurance, and health services and products primarily in Peru and internationally. It operates through Universal Banking, Insurance and Pensions, Microfinance, and Investment Banking and Equity Management segments. The Universal Banking segment grants various credits and financial instruments to individuals and legal entities; and various deposits and current accounts.
See Also
- Five stocks we like better than Credicorp
- How to Capture the Benefits of Dividend Increases
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- 3 Stocks to Consider Buying in October
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Find and Profitably Trade Stocks at 52-Week Lows
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Want to see what other hedge funds are holding BAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Credicorp Ltd. (NYSE:BAP – Free Report).
Receive News & Ratings for Credicorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Credicorp and related companies with MarketBeat.com's FREE daily email newsletter.